← Leaderboards
M-C Gauduin
Harvard University (Medical School)
$2,850,684
Attributed
$2,850,684
Total exposure
12
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $672.4K · FY2005–07$1M$750K$500K$250K$0
'05
'06
'07
Funding mix
By agency
NIH$2,850,684 · 12
By mechanism
P51$2,850,684 · 12
Top collaborators
No co-investigators on record.
Most similar at Harvard University (Medical School)
Same institution · by research overlap
- R. Paul Johnson$56,310,063
- Keith G. Mansfield$12,495,552
- Andrew A Lackner$56,391,965
- Ronald C Desrosiers$52,941,615
- Zheng W Chen$26,721,709
Others in their field
Top investigators on “Macaca”
- Barton F Haynes · Duke University$291,402,363
- Peter Gordon Gillespie · Oregon Health And Science University$96,229,141
- Richard A Gibbs · Baylor College Of Medicine$82,807,896
- Dennis R. Burton · Scripps Research Institute$75,153,374
- Larry S. Schlesinger · Texas Biomedical Research Institute$72,536,876
- Dan H. Barouch · Fred Hutchinson Cancer Center$68,546,715
Research focus
MacacaHelper T LymphocyteAnimal ColonySimian Immunodeficiency VirusRetroviridae DiseaseCellular ImmunitySourceCd4 Positive T LymphocytesResourcesResearch PersonnelAnimalsCellsImmune ResponseComputer Retrieval Of Information On Scientific Projects DatabaseCytotoxic T LymphocyteGaggingGrantImmunityResponseInstitutionMicroorganism ImmunologyFrequencies (Time Pattern)FundingUnited States National Institutes Of Health
Grant awards (16)
EFFICACY OF A DNA/MVA VACCINE TO PROTECT AGAINST REPEATED VAGINAL SIV CHALLENGE$52,049
P51 · FY2007 · RR · contact PI
INDUCTION OF A EFFECTOR MEMORY CD4+ T CELL RESPONSE BY ATTENUATED SIV$52,049
P51 · FY2007 · RR · contact PI
INDUCTION OF A EFFECTOR MEMORY CD4+ T CELL RESPONSE BY ATTENUATED SIV$134,807
P51 · FY2006 · RR · contact PI
EFFICACY OF A DNA/MVA VACCINE TO PROTECT AGAINST REPEATED VAGINAL SIV CHALLENGE$134,807
P51 · FY2006 · RR · contact PI
IDENTIFICATION OF SIV-SPECIFIC T HELPER EPITOPES AND THEIR RESTRICTING ALLELES$168,102
P51 · FY2005 · RR
CD8-DEPLETION OF EARLY TREATED SIV-INFECTED MACAQUES RESULTS IN REBOUND VIREMIA$168,102
P51 · FY2005 · RR
SIV-SPECIFIC CD4+ AND CD8+ T CELL RESPONSES DURING ACUTE SIV INFECTION$168,102
P51 · FY2005 · RR
OPTIMIZATION OF ICS FOR QUANTITATION OF AG-SPECIFIC CD4+ RESPONSES IN MACAQUES$168,102
P51 · FY2005 · RR
OPTIMIZATION OF ICS FOR QUANTITATION OF AG-SPECIFIC CD4+ RESPONSES IN MACAQUES$204,218
P51 · FY2004 · RR
IDENTIFICATION OF SIV-SPECIFIC T HELPER EPITOPES$204,218
P51 · FY2004 · RR
CD8-DEPLETION OF EARLY TREATED SIV-INFECTED MACAQUES$204,218
P51 · FY2004 · RR
CD4+ &CD8+ T CELL RESPONSES DURING ACUTE SIV INFECTION$204,218
P51 · FY2004 · RR
IDENTIFICATION OF SIV-SPECIFIC CELLS USING INTRACELLULAR CYTOKINE STAINING (ICC)$246,923
P51 · FY2003 · RR
ANALYSIS OF SIV-SPECIFIC CD8+ T CELL RESPONSES IN SIV-INFECTED NEONATAL MACAQUES$246,923
P51 · FY2003 · RR
IMPACT OF EARLY ANTIRETROVIRAL THERAPY ON SIV-SPECIFIC T CELL RESPONSES MACAQUES$246,923
P51 · FY2003 · RR
IDENTIFICATION OF SIV-SPECIFIC T HELPER EPITOPES AND THEIR RESTRICTING ALLELES$246,923
P51 · FY2003 · RR